U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07626736) titled 'Evaluating the Efficacy and Safety of AI Localization Models in Multidisciplinary Team Care for NSCLC' on March 25.
Brief Summary: The goal of this clinical trial is to evaluate the effectiveness and safety of a locally deployed artificial intelligence (AI) decision-support model in the multidisciplinary team (MDT) process for patients with non-small cell lung cancer (NSCLC).
The main questions it aims to answer :
What is the level of agreement between treatment recommendations generated by the AI model and those made by a traditional MDT? How often do clinicians modify their final treatment decision after reviewing the AI model's ...